Phibro Animal Health Corp. A buy JPMorgan Chase & Co.
Start price
07.07.25
/
50%
€25.80
Target price
07.07.26
€29.73
Performance (%)
78.45%
Price
27.02.26
€45.80
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Phibro Animal Health Corp. A has seen massive gains of 78.45%. Dividends of €0.24 are taken into consideration when calculating the performance. This prediction currently runs until 07.07.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Phibro Animal Health Corp. A | 3.620% | 3.620% |
| iShares Core DAX® | -1,31 % | -0,78 % |
| iShares Nasdaq 100 | 1,98 % | -2,04 % |
| iShares Nikkei 225® | 0,59 % | 6,71 % |
| iShares S&P 500 | 1,42 % | -0,48 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Phibro Animal Health Corp. A diskutieren
Phibro Animal Health Corporation (NASDAQ: PAHC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $35.00 price target on the stock, up previously from $25.00.
Ratings data for PAHC provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Phibro Animal Health Corp. A
Phibro Animal Health Corp. A
Start price
Target price
Perf. (%)
€38.40
07.11.25
07.11.25
€43.34
07.11.26
07.11.26
21.67%
27.02.26
27.02.26
